Evolutionary dynamics of carcinogenesis and why targeted therapy does not work (original) (raw)

• Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23–28 (1976).
  Article CAS PubMed Google Scholar
• Jones, S. et al. Comparative lesion sequencing provides insights into tumor evolution. Proc. Natl Acad. Sci. USA 105, 4283–4288 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883–892 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Gerlinger, M. & Swanton, C. How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine. Br. J. Cancer 103, 1139–1143 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306–313 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Gatenby, R. A., Gillies, R. J. & Brown, J. S. Of cancer and cave fish. Nature Rev. Cancer 11, 237–238 (2011).
  Article CAS Google Scholar
• Gillies, R. J., Robey, I. & Gatenby, R. A. Causes and consequences of increased glucose metabolism of cancers. J. Nucl Med 49 Suppl 2, 24S–42S (2008).
  Article CAS PubMed Google Scholar
• Allred, D. C. et al. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin. Cancer Res. 14, 370–378 (2008).
  Article CAS PubMed Google Scholar
• Gatenby, R. A. & Gillies, R. J. A microenvironmental model of carcinogenesis. Nature Rev. Cancer 8, 56–61 (2008).
  Article CAS Google Scholar
• Gatenby, R. A. & Gillies, R. J. Why do cancers have high aerobic glycolysis? Nature Rev. Cancer 4, 891–899 (2004).
  Article CAS Google Scholar
• Loeb, L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51, 3075–3079 (1991).
  CAS PubMed Google Scholar
• Cahill, D. P., Kinzler, K. W., Vogelstein, B. & Lengauer, C. Genetic instability and darwinian selection in tumours. Trends Cell Biol. 9, M57–M60 (1999).
  Article CAS PubMed Google Scholar
• Garber, J. E. & Offit, K. Hereditary cancer predisposition syndromes. J. Clin. Oncol. 23, 276–292 (2005).
  Article PubMed Google Scholar
• Chung, C. C. & Chanock, S. J. Current status of genome-wide association studies in cancer. Hum. Genet. 130, 59–78 (2011).
  Article PubMed Google Scholar
• Negrini, S., Gorgoulis, V. G. & Halazonetis, T. D. Genomic instability--an evolving hallmark of cancer. Nature Rev. Mol. Cell Biol. 11, 220–228 (2010).
  Article CAS Google Scholar
• Podsypanina, K. et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl Acad. Sci. USA 96, 1563–1568 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Michiels, F. M. et al. Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation. Proc. Natl Acad. Sci. USA 94, 3330–3335 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Ferrara, N. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439–442 (1996).
  Article CAS PubMed Google Scholar
• Zhang, Q. et al. Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments. Science 333, 1764–1767 (2011).
  Article CAS PubMed Google Scholar
• Davies, P. C. & Lineweaver, C. H. Cancer tumors as Metazoa 1.0: tapping genes of ancient ancestors. Phys. Biol. 8, 015001 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Goncharova, E. I., Nadas, A. & Rossman, T. G. Serum deprivation, but not inhibition of growth per se, induces a hypermutable state in Chinese hamster G12 cells. Cancer Res. 56, 752–756 (1996).
  CAS PubMed Google Scholar
• Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
  Article CAS PubMed Google Scholar
• Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883–899 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Aggarwal, B. B., Vijayalekshmi, R. V. & Sung, B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin. Cancer Res. 15, 425–430 (2009).
  Article CAS PubMed Google Scholar
• Papp-Szabo, E., Josephy, P. D. & Coomber, B. L. Microenvironmental influences on mutagenesis in mammary epithelial cells. Int. J. Cancer 116, 679–685 (2005).
  Article CAS PubMed Google Scholar
• Reynolds, T. Y., Rockwell, S. & Glazer, P. M. Genetic instability induced by the tumor microenvironment. Cancer Res. 56, 5754–5757 (1996).
  CAS PubMed Google Scholar
• Wilkinson, D., Sandhu, J. K., Breneman, J. W., Tucker, J. D. & Birnboim, H. C. Hprt mutants in a transplantable murine tumour arise more frequently in vivo than in vitro. Br. J. Cancer 72, 1234–1240 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. & Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129–1136 (1990).
  Article CAS PubMed Google Scholar
• Brechot, C., Pourcel, C., Louise, A., Rain, B. & Tiollais, P. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 286, 533–535 (1980).
  Article CAS PubMed Google Scholar
• Anand, P. et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res. 25, 2097–2116 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Minamoto, T., Mai, M. & Ronai, Z. Environmental factors as regulators and effectors of multistep carcinogenesis. Carcinogenesis 20, 519–527 (1999).
  Article CAS PubMed Google Scholar
• DeMarini, D. M. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat. Res. 567, 447–474 (2004).
  Article CAS PubMed Google Scholar
• Ikehata, H. & Ono, T. The mechanisms of UV mutagenesis. J. Radiat. Res. 52, 115–125 (2011).
  Article CAS PubMed Google Scholar
• Chitneni, S. K., Palmer, G. M., Zalutsky, M. R. & Dewhirst, M. W. Molecular imaging of hypoxia. J. Nucl. Med. 52, 165–168 (2011).
  Article CAS PubMed Google Scholar
• Wykoff, C. C. et al. Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am. J. Pathol. 158, 1011–1019 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Gillies, R. J. & Gatenby, R. A. Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis? J. Bioenerg. Biomembr. 39, 251–257 (2007).
  Article CAS PubMed Google Scholar
• Bristow, R. G. & Hill, R. P. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nature Rev. Cancer 8, 180–192 (2008).
  Article CAS Google Scholar
• Klein, T. J. & Glazer, P. M. The tumor microenvironment and DNA repair. Semin. Radiat. Oncol. 20, 282–287 (2010).
  Article PubMed PubMed Central Google Scholar
• Lu, Y., Chu, A., Turker, M. S. & Glazer, P. M. Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter. Mol. Cell. Biol. 31, 3339–3350 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Mihaylova, V. T. et al. Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol. Cell. Biol. 23, 3265–3273 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Hammond, E. M., Dorie, M. J. & Giaccia, A. J. ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J. Biol. Chem. 278, 12207–12213 (2003).
  Article CAS PubMed Google Scholar
• Graeber, T. G. et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379, 88–91 (1996).
  Article CAS PubMed Google Scholar
• Shi, Q. et al. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin. Cancer Res. 5, 3711–3721 (1999).
  CAS PubMed Google Scholar
• Bindra, R. S. & Glazer, P. M. Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis. Mutat. Res. 569, 75–85 (2005).
  Article CAS PubMed Google Scholar
• Young, S. D., Marshall, R. S. & Hill, R. P. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc. Natl Acad. Sci. USA 85, 9533–9537 (1988).
  Article CAS PubMed PubMed Central Google Scholar
• Rice, G. C., Hoy, C. & Schimke, R. T. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc. Natl Acad. Sci. USA 83, 5978–5982 (1986).
  Article CAS PubMed PubMed Central Google Scholar
• Otsuka, J. The large-scale evolution by generating new genes from gene duplication; similarity and difference between monoploid and diploid organisms. J. Theor. Biol. 278, 120–126 (2011).
  Article PubMed Google Scholar
• van Sluis, R. et al. In vivo imaging of extracellular pH using 1H MRSI. Magn. Reson. Med. 41, 743–750 (1999).
  Article CAS PubMed Google Scholar
• Gillies, R. J., Liu, Z. & Bhujwalla, Z. 31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. Am. J. Physiol. 267, C195–203 (1994).
  Article CAS PubMed Google Scholar
• Morita, T., Nagaki, T., Fukuda, I. & Okumura, K. Clastogenicity of low pH to various cultured mammalian cells. Mutat. Res. 268, 297–305 (1992).
  Article CAS PubMed Google Scholar
• Zhang, H. Y., Hormi-Carver, K., Zhang, X., Spechler, S. J. & Souza, R. F. In benign Barrett's epithelial cells, acid exposure generates reactive oxygen species that cause DNA double-strand breaks. Cancer Res. 69, 9083–9089 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Xiao, H., Li, T. K., Yang, J. M. & Liu, L. F. Acidic pH induces topoisomerase II-mediated DNA damage. Proc. Natl Acad. Sci. USA 100, 5205–5210 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Hashim, A. I., Zhang, X., Wojtkowiak, J. W., Martinez, G. V. & Gillies, R. J. Imaging pH and metastasis. NMR Biomed. 24, 582–591 (2011).
  PubMed PubMed Central Google Scholar
• Webb, B. A., Chimenti, M., Jacobson, M. P. & Barber, D. L. Dysregulated pH: a perfect storm for cancer progression. Nature Rev. Cancer 11, 671–677 (2011).
  Article CAS Google Scholar
• Radu, C. G., Nijagal, A., McLaughlin, J., Wang, L. & Witte, O. N. Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells. Proc. Natl Acad. Sci. USA 102, 1632–1637 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Leffler, A., Monter, B. & Koltzenburg, M. The role of the capsaicin receptor TRPV1 and acid-sensing ion channels (ASICS) in proton sensitivity of subpopulations of primary nociceptive neurons in rats and mice. Neuroscience 139, 699–709 (2006).
  Article CAS PubMed Google Scholar
• Dong, X. et al. Expression of acid-sensing ion channels in intestinal epithelial cells and their role in the regulation of duodenal mucosal bicarbonate secretion. Acta Physiol. (Oxf.) 201, 97–107 (2011).
  Article CAS Google Scholar
• Yun, J. et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 325, 1555–1559 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Rose, C. J. et al. Quantifying spatial heterogeneity in dynamic contrast-enhanced MRI parameter maps. Magn. Reson. Med. 62, 488–499 (2009).
  Article PubMed Google Scholar
• Kawata, Y. et al. Quantitative classification based on CT histogram analysis of non-small cell lung cancer: Correlation with histopathological characteristics and recurrence-free survival. Med. Phys. 39, 988 (2012).
  Article PubMed Google Scholar
• Drew, P. J. et al. Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer. Ann. Surg. Oncol. 6, 599–603 (1999).
  Article CAS PubMed Google Scholar
• Knopp, M. V., Giesel, F. L., Marcos, H., von Tengg-Kobligk, H. & Choyke, P. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Top. Magn. Reson. Imag. 12, 301–308 (2001).
  Article CAS Google Scholar
• Lamer, S. et al. Radiologic assessment of intranodal vascularity in head and neck squamous cell carcinoma. Correlation with histologic vascular density. Invest. Radiol 31, 673–679 (1996).
  Article CAS PubMed Google Scholar
• Venkatasubramanian, R., Arenas, R. B., Henson, M. A. & Forbes, N. S. Mechanistic modelling of dynamic MRI data predicts that tumour heterogeneity decreases therapeutic response. Br. J. Cancer 103, 486–497 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Helmlinger, G., Yuan, F., Dellian, M. & Jain, R. K. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nature Med. 3, 177–182 (1997).
  Article CAS PubMed Google Scholar
• Kimura, H. et al. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res. 56, 5522–5528 (1996).
  CAS PubMed Google Scholar
• Costouros, N. G. et al. Microarray gene expression analysis of murine tumor heterogeneity defined by dynamic contrast-enhanced MRI. Mol. Imag. 1, 301–308 (2002).
  Article CAS Google Scholar
• Guccione, S. et al. Functional genomics guided with MR imaging: mouse tumor model study. Radiology 228, 560–568 (2003).
  Article PubMed Google Scholar
• Hobbs, S. K. et al. Magnetic resonance image-guided proteomics of human glioblastoma multiforme. J. Magn. Reson. Imag. 18, 530–536 (2003).
  Article Google Scholar
• Winge, O. Zytologische untersuchungen uber die natur maligner tumoren. II. Teerkarzinome bei mausen. Z. Zellforsch. Mikrosk. Anat. 10, 683–735 (1930).
  Article Google Scholar
• Sandberg, A. A. & Hossfeld, D. K. Chromosomal abnormalities in human neoplasia. Annu. Rev. Med. 21, 379–408 (1970).
  Article CAS PubMed Google Scholar
• Bakhoum, S. F., Danilova, O. V., Kaur, P., Levy, N. B. & Compton, D. A. Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma. Clin. Cancer Res. 17, 7704–7711 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Loeb, L. A. Human cancers express mutator phenotypes: origin, consequences and targeting. Nature Rev. Cancer 11, 450–457 (2011).
  Article CAS Google Scholar
• Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114–1117 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Araujo, R. P., Liotta, L. A. & Petricoin, E. F. Proteins, drug targets and the mechanisms they control: the simple truth about complex networks. Nature Rev. Drug Discov. 6, 871–880 (2007).
  Article CAS Google Scholar
• Lage, H. An overview of cancer multidrug resistance: a still unsolved problem. Cell. Mol. Life Sci. 65, 3145–3167 (2008).
  Article CAS PubMed Google Scholar
• Marty, M. et al. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. J. Clin. Oncol. 23, 4265–4274 (2005).
  Article CAS PubMed Google Scholar
• Mahtani, R. L. & Vogel, C. L. Pleomorphic lobular carcinoma of the breast: four long-term responders to trastuzumab--coincidence or hint? J. Clin. Oncol. 26, 5823–5824 (2008).
  Article PubMed Google Scholar
• Untch, M. et al. Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups. J. Clin. Oncol. 29, 3351–3357 (2011).
  Article CAS PubMed Google Scholar
• Druker, B. J. et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N. Engl. J. Med. 355, 2408–2417 (2006).
  Article CAS PubMed Google Scholar
• Engelman, J. A. & Settleman, J. Acquired resistance to tyrosine kinase inhibitors during cancer therapy. Curr. Opin. Genet. Dev. 18, 73–79 (2008).
  Article CAS PubMed Google Scholar
• Aktipis, C. A., Kwan, V. S., Johnson, K. A., Neuberg, S. L. & Maley, C. C. Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research. PLoS ONE 6, e26100 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• O'Hare, T., Corbin, A. S. & Druker, B. J. Targeted CML therapy: controlling drug resistance, seeking cure. Curr. Opin. Genet. Dev. 16, 92–99 (2006).
  Article CAS PubMed Google Scholar
• Blackwell, K. L. et al. Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer. J. Clin. Oncol. 28, 1124–1130 (2010).
  Article CAS PubMed Google Scholar
• Massarweh, S. & Schiff, R. Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk. Endocr. Relat. Cancer 13 Suppl. 1, 15–24 (2006).
  Article CAS Google Scholar
• Baselga, J. et al. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N. Engl. J. Med. 366, 520–529 (2012).
  Article CAS PubMed Google Scholar
• Komarova, N. L. & Wodarz, D. Drug resistance in cancer: principles of emergence and prevention. Proc. Natl Acad. Sci. USA 102, 9714–9719 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Chmielecki, J. et al. Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling. Sci Transl Med 3, 90ra59 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Gatenby, R. A., Brown, J. & Vincent, T. Lessons from applied ecology: cancer control using an evolutionary double bind. Cancer Res. 69, 7499–7502 (2009).
  Article CAS PubMed Google Scholar
• Gatenby, R. A., Silva, A. S., Gillies, R. J. & Frieden, B. R. Adaptive therapy. Cancer Res. 69, 4894–4903 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Mirski, S. E., Gerlach, J. H. & Cole, S. P. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Cancer Res. 47, 2594–2598 (1987).
  CAS PubMed Google Scholar
• Abrahamsson, P. A. Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature. Eur. Urol. 57, 49–59 (2010).
  Article CAS PubMed Google Scholar
• Beex, L. et al. Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: an EORTC phase III study (10863). Eur. J. Cancer 42, 3178–3185 (2006).
  Article CAS PubMed Google Scholar
• Farber, S. & Diamond, L. K. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. N. Engl. J. Med. 238, 787–793 (1948).
  Article CAS PubMed Google Scholar
• De Bock, K., Mazzone, M. & Carmeliet, P. Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? Nature Rev. Clin. Oncol. 8, 393–404 (2011).
  Article CAS Google Scholar
• Iwamoto, F. M. et al. Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma. Neurology 73, 1200–1206 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Jain, R. K. Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer. Nature Rev. Cancer 8, 309–316 (2008).
  Article CAS Google Scholar
• Goel, S. et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol. Rev. 91, 1071–1121 (2011).
  Article CAS PubMed Google Scholar
• Chan, D. A. et al. Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. Sci Transl Med 3, 94ra70 (2011).
  CAS PubMed PubMed Central Google Scholar
• Ganapathy-Kanniappan, S. et al. 3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy. Curr. Pharm. Biotechnol. 11, 510–517 (2010).
  Article CAS PubMed Google Scholar
• Michelakis, E. D., Webster, L. & Mackey, J. R. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br. J. Cancer 99, 989–994 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Le, A. et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc. Natl Acad. Sci. USA 107, 2037–2042 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Gatenby, R. A., Gawlinski, E. T., Gmitro, A. F., Kaylor, B. & Gillies, R. J. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 66, 5216–5223 (2006).
  Article CAS PubMed Google Scholar
• Ibrahim Hashim, A. et al. Reduction of metastasis using a non-volatile buffer. Clin. Exp. Metastasis 28, 841–849 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Hashim, A. I. et al. Sytemic buffers inhibit carcinogenesis in TRAMP mice. J. Urology (2012). (in press Jan, </pub>2012).
• Ibrahim Hashim, A. et al. Reduction of metastasis using a non-volatile buffer. Clin Exp Metastasis (2011).
• Wojtkowiak, J. W., Verduzco, D., Schramm, K. J. & Gillies, R. J. Drug resistance and cellular adaptation to tumor acidic pH microenvironment. Mol. Pharm. 8, 2032–2038 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Ghobrial, I. M., Witzig, T. E. & Adjei, A. A. Targeting apoptosis pathways in cancer therapy. CA Cancer J. Clin. 55, 178–194 (2005).
  Article PubMed Google Scholar
• Ludwig, H., Khayat, D., Giaccone, G. & Facon, T. Proteasome inhibition and its clinical prospects in the treatment of hematologic and solid malignancies. Cancer 104, 1794–1807 (2005).
  Article CAS PubMed Google Scholar
• Madhok, B. M., Yeluri, S., Perry, S. L., Hughes, T. A. & Jayne, D. G. Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells. Br. J. Cancer 102, 1746–1752 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Holoch, P. A. & Griffith, T. S. TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies. Eur. J. Pharmacol. 625, 63–72 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Smolewski, P. Recent developments in targeting the mammalian target of rapamycin (mTOR) kinase pathway. Anticancer Drugs 17, 487–494 (2006).
  Article CAS PubMed Google Scholar
• Agulnik, M. New developments in mammalian target of rapamycin inhibitors for the treatment of sarcoma. Cancer 118, 1486–1497 (2012).
  Article CAS PubMed Google Scholar
• Houghton, P. J. Everolimus. Clin. Cancer Res. 16, 1368–1372 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Pouget, J. P. et al. Clinical radioimmunotherapy--the role of radiobiology. Nature Rev. Clin. Oncol. 8, 720–734 (2011).
  Article CAS Google Scholar
• Richman, C. M. et al. High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody. Clin. Cancer Res. 11, 5920–5927 (2005).
  Article CAS PubMed Google Scholar
• Behr, T. M. et al. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model. Cancer Res. 59, 2635–2643 (1999).
  CAS PubMed Google Scholar
• Chatal, J. F., Davodeau, F., Cherel, M. & Barbet, J. Different ways to improve the clinical effectiveness of radioimmunotherapy in solid tumors. J. Cancer Res. Ther. 5 Suppl. 1, S36–40 (2009).
  Article CAS PubMed Google Scholar
• Wilson, W. R. & Hay, M. P. Targeting hypoxia in cancer therapy. Nature Rev. Cancer 11, 393–410 (2011).
  Article CAS Google Scholar
• Duan, J. X. et al. Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs. J. Med. Chem. 51, 2412–2420 (2008).
  Article CAS PubMed Google Scholar
• Meng, F. et al. Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302. Mol. Cancer Ther. 6, 6 (2011).
  Google Scholar
• Sun, J. D. et al. Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer. Clin. Cancer Res. 18, 758–770 (2011).
  Article PubMed Google Scholar
• Tian, L. & Bae, Y. H. Cancer nanomedicines targeting tumor extracellular pH. Colloids Surf B Biointerfaces DOI colsurfb.2011.10.039 (2011).
• Kaminskas, L. M. et al. Doxorubicin-conjugated PEGylated dendrimers show similar tumoricidal activity but lower systemic toxicity when compared to PEGylated liposome and solution formulations in mouse and rat tumor models. Mol. Pharm. 9, 422–432 (2012).
  Article CAS PubMed Google Scholar
• Gatenby, R. A. & Vincent, T. L. Application of quantitative models from population biology and evolutionary game theory to tumor therapeutic strategies. Mol. Cancer Ther. 2, 919–927 (2003).
  CAS PubMed Google Scholar
• Casanueva, M. O., Burga, A. & Lehner, B. Fitness trade-offs and environmentally induced mutation buffering in isogenic C. elegans. Science 335, 82–85 (2012).
  Article CAS PubMed Google Scholar
• Jacob, F. Evolution and Tinkering. Science 196, 1161–1166 (1977).
  Article CAS PubMed Google Scholar